User profiles for J. Vojinovic
 | Jelena VojinovicProf MD PhD Verified email at medfak.ni.ac.rs Cited by 2631 |
EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice
…, N Tzaribachev, MA Van Rossum, J Vojinovic… - Annals of the …, 2015 - ard.bmj.com
To develop evidence based points to consider the use of imaging in the diagnosis and
management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a …
management of juvenile idiopathic arthritis (JIA) in clinical practice. The task force comprised a …
[HTML][HTML] HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis
J Vojinovic, N Damjanov - Molecular Medicine, 2011 - Springer
Rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) are heterogeneous autoimmune
diseases characterized by chronic joint inflammation. Methotrexate is used as the gold …
diseases characterized by chronic joint inflammation. Methotrexate is used as the gold …
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire …
Objective To collect data on vitamin D (25(OH)D) serum levels in a large number of rheumatoid
arthritis (RA) patients from different European countries, to investigate their relation with …
arthritis (RA) patients from different European countries, to investigate their relation with …
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial
…, S Oliveira, W Armbrust, S Garay, J Vojinovic… - Jama, 2010 - jamanetwork.com
Context Novel therapies have improved the remission rate in chronic inflammatory disorders
including juvenile idiopathic arthritis (JIA). Therefore, strategies of tapering therapy and …
including juvenile idiopathic arthritis (JIA). Therefore, strategies of tapering therapy and …
[PDF][PDF] Disease modifying and immunomodulatory effects of high dose 1 (OH) D3 in rheumatoid arthritis patients
Z Andjelkovic, J Vojinovic, N Pejnovic… - Clinical and …, 1999 - academia.edu
Methods We organized a 3-month open-label trial on 19 patients being treated with standard
DMARD therapy for acute RA. They were divided into 2 subgroups, those with highly active …
DMARD therapy for acute RA. They were divided into 2 subgroups, those with highly active …
Safety and efficacy of an oral histone deacetylase inhibitor in systemic‐onset juvenile idiopathic arthritis
J Vojinovic, N Damjanov, C D'Urzo… - Arthritis & …, 2011 - Wiley Online Library
… ‐onset juvenile idiopathic arthritis - Vojinovic - 2011 - Arthritis & Rheumatism - Wiley Online
Library … Vojinovic had full access to all of the data in the study and takes responsibility for the …
Library … Vojinovic had full access to all of the data in the study and takes responsibility for the …
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
…, G Vijatov-Djuric, S Vilaiyuk, J Vojinovic… - The Lancet Child & …, 2019 - thelancet.com
Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional study…
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of …
…, J Vojinovic, VG Chasnyk, J Dehoorne… - Annals of the …, 2014 - ard.bmj.com
Objective To investigate the efficacy and safety of etanercept (ETN) in paediatric subjects
with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA)…
with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA)…
Preliminary definitions for the sonographic features of synovitis in children
…, P Vega‐Fernandez, J Vojinovic… - Arthritis care & …, 2017 - Wiley Online Library
… Vojinovic has received speaking fees from AbbVie, Pfizer, and Roche (less than $10,000
each). Address correspondence to Johannes Roth, MD, PhD, FRCPC, RhMSUS, Children’s …
each). Address correspondence to Johannes Roth, MD, PhD, FRCPC, RhMSUS, Children’s …
Toward standardized musculoskeletal ultrasound in pediatric rheumatology: normal age‐related ultrasound findings
P Collado, J Vojinovic, JC Nieto… - Arthritis care & …, 2016 - Wiley Online Library
Objective The Outcome Measures in Rheumatology Ultrasound Task Force has recently
started to work on the validation and standardization of musculoskeletal ultrasound (MSUS) …
started to work on the validation and standardization of musculoskeletal ultrasound (MSUS) …